High-dose intravenous immunoglobulin therapy in dysimmune neuropathies

Neurol Sci. 2002 Apr:23 Suppl 1:S25-32. doi: 10.1007/s100720200012.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Dose-Response Relationship, Drug
  • Guillain-Barre Syndrome / drug therapy
  • Guillain-Barre Syndrome / immunology
  • Guillain-Barre Syndrome / physiopathology
  • Humans
  • Immunization, Passive / adverse effects
  • Immunization, Passive / methods*
  • Immunoglobulins, Intravenous / administration & dosage*
  • Immunoglobulins, Intravenous / adverse effects
  • Motor Neuron Disease / drug therapy
  • Motor Neuron Disease / immunology
  • Motor Neuron Disease / physiopathology
  • Paraproteinemias / drug therapy
  • Paraproteinemias / immunology
  • Paraproteinemias / physiopathology
  • Peripheral Nervous System Diseases / drug therapy*
  • Peripheral Nervous System Diseases / immunology
  • Peripheral Nervous System Diseases / physiopathology
  • Polyradiculoneuropathy / drug therapy*
  • Polyradiculoneuropathy / immunology
  • Polyradiculoneuropathy / physiopathology
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / immunology
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / physiopathology

Substances

  • Immunoglobulins, Intravenous